Login Register Cart 0
Generic placeholder image

Current Rheumatology Reviews

Editor-in-Chief

ISSN (Print): 1573-3971
ISSN (Online): 1875-6360

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Serum Level of Soluble Human Leukocyte Antigen G in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis

Author(s): Zahra Rezaieyazdi, Amin Rezaeian and Mandana khodashahi*

Volume 19, Issue 1, 2023

Published on: 15 August, 2022

Page: [64 - 71] Pages: 8

DOI: 10.2174/1573397118666220617100226

Price: $65

Abstract

Background: This study aimed to evaluate the serum level of human leukocyte antigen G [HLA-G] in patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) compared to healthy controls; moreover, it attempted to assess its relationship with SLE and RA disease activity indices.

Methods: This descriptive study was conducted on 31 SLE patients (17 cases with a recent diagnosis and 14 cases with a previous diagnosis), 21 RA patients (7 cases with a recent diagnosis and 14 cases with a previous diagnosis), and 18 healthy controls who visited Ghaem Hospital affiliated to Mashhad University of Medical Sciences, Mahhad, Iran. SLE and RA activity indices were measured and recorded. Furthemore, soluble isoforms, including shed HLA-G1 and HLA-G5, were measured in serum samples via the ELISA method.

Results: A comparison of the five groups showed no significant differences in the serum level of sHLA-G. However, sHLA-G serum level was significantly higher in SLE and RA patients compared to healthy controls (P<0.05). sHLA-G level showed no correlation with disease duration and activity in SLE and RA patients (P>0.05). However, a strong positive correlation was observed between the serum level of sHLA-G and 24-h urine protein in the previously diagnosed SLE group (r=0.83, P=0.01).

Conclusion: It seems that the serum level of sHLA-G is higher in RA and SLE patients compared to healthy controls. Furthermore, a strong correlation was found between sHLA-G serum levels and 24-h urine protein in cases with a previous diagnosis of SLE.

Keywords: Human leukocyte antigen G, inflammatory diseases, rheumatoid arthritis, systemic lupus erythematosus.

« Previous Next »
Graphical Abstract

[1]
Zhang Y, Zhao J, Qiu L, et al. Co-expression of ILT4/HLA-G in human non-small cell lung cancer correlates with poor prognosis and ILT4-HLA-G interaction activates ERK signaling. Tumour Biol 2016; 37(8): 11187-98.
[http://dx.doi.org/10.1007/s13277-016-5002-5] [PMID: 26939901]
[2]
Lin A, Yan W-H. Human leukocyte antigen-G (HLA-G) expression in cancers: Roles in immune evasion, metastasis and target for therapy. Mol Med 2015; 21(1): 782-91.
[http://dx.doi.org/10.2119/molmed.2015.00083] [PMID: 26322846]
[3]
Kanai T, Fujii T, Unno N, et al. Human leukocyte antigen-G-expressing cells differently modulate the release of cytokines from mononuclear cells present in the decidua versus peripheral blood. Am J Reprod Immunol 2001; 45(2): 94-9.
[http://dx.doi.org/10.1111/j.8755-8920.2001.450205.x] [PMID: 11216880]
[4]
Feger U, Tolosa E, Huang Y-H, et al. HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. Blood 2007; 110(2): 568-77.
[http://dx.doi.org/10.1182/blood-2006-11-057125] [PMID: 17371944]
[5]
Monsiváis-Urenda AE, Baranda L, Alvarez-Quiroga C, Abud-Mendoza C, González-Amaro R. Expression and functional role of HLA-G in immune cells from patients with systemic lupus erythematosus. J Clin Immunol 2011; 31(3): 369-78.
[http://dx.doi.org/10.1007/s10875-010-9496-0] [PMID: 21188486]
[6]
Wan R, Wang Z-W, Li H, et al. Human leukocyte antigen-G inhibits the anti-tumor effect of natural killer cells via immunoglobulin-like transcript 2 in gastric cancer. Cell Physiol Biochem 2017; 44(5): 1828-41.
[http://dx.doi.org/10.1159/000485819] [PMID: 29224003]
[7]
LeMaoult J, Krawice-Radanne I, Dausset J, Carosella ED. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci USA 2004; 101(18): 7064-9.
[http://dx.doi.org/10.1073/pnas.0401922101] [PMID: 15103024]
[8]
Xia D, Hao S, Xiang J. CD8+ cytotoxic T-APC stimulate central memory CD8+ T cell responses via acquired peptide-MHC class I complexes and CD80 costimulation, and IL-2 secretion. J Immunol 2006; 177(5): 2976-84.
[http://dx.doi.org/10.4049/jimmunol.177.5.2976] [PMID: 16920933]
[9]
LeMaoult J, Caumartin J, Daouya M, et al. Immune regulation by pretenders: Cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 2007; 109(5): 2040-8.
[http://dx.doi.org/10.1182/blood-2006-05-024547] [PMID: 17077329]
[10]
Zheng X-Q, Li C-C, Xu D-P, et al. Analysis of the plasma soluble human leukocyte antigen-G and interleukin-10 levels in childhood atopic asthma. Hum Immunol 2010; 71(10): 982-7.
[http://dx.doi.org/10.1016/j.humimm.2010.06.018] [PMID: 20600443]
[11]
Menier C, Rouas-Freiss N, Favier B, LeMaoult J, Moreau P, Carosella ED. Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule. Tissue Antigens 2010; 75(3): 201-6.
[http://dx.doi.org/10.1111/j.1399-0039.2009.01438.x] [PMID: 20047640]
[12]
Cai Z, Wang L, Han Y, et al. Immunoglobulin-like transcript 4 and human leukocyte antigen-G interaction promotes the progression of human colorectal cancer. Int J Oncol 2019; 54(6): 1943-54.
[http://dx.doi.org/10.3892/ijo.2019.4761] [PMID: 30942436]
[13]
Dahl M, Perin TL, Djurisic S, et al. Soluble human leukocyte antigen-G in seminal plasma is associated with HLA-G genotype: Possible implications for fertility success. Am J Reprod Immunol 2014; 72(1): 89-105.
[http://dx.doi.org/10.1111/aji.12251] [PMID: 24735563]
[14]
Dedmon LE. The genetics of rheumatoid arthritis. Rheumatology (Oxford) 2020; 59(10): 2661-70.
[http://dx.doi.org/10.1093/rheumatology/keaa232] [PMID: 32638005]
[15]
Ha E, Sang-Cheol B, Kim K. Recent advances in understanding the genetic basis of systemic lupus erythematosus. Semin Immunopathol 2022; 44(1): 29-46.
[16]
Zharkova O, Celhar T, Cravens PD, Satterthwaite AB, Fairhurst A-M, Davis LS. Pathways leading to an immunological disease: Systemic lupus erythematosus. Rheumatology (Oxford) 2017; 56 (Suppl. 1): i55-66.
[http://dx.doi.org/10.1093/rheumatology/kew427] [PMID: 28375453]
[17]
Liu Y, Dong J, Mu R, et al. MicroRNA-30a promotes B cell hyperactivity in patients with systemic lupus erythematosus by direct interaction with Lyn. Arthritis Rheum 2013; 65(6): 1603-11.
[http://dx.doi.org/10.1002/art.37912] [PMID: 23450709]
[18]
Cavalcanti A, Almeida R, Mesquita Z, Duarte ALBP, Donadi EA, Lucena-Silva N. Gene polymorphism and HLA-G expression in patients with childhood-onset systemic lupus erythematosus: A pilot study. HLA 2017; 90(4): 219-27.
[http://dx.doi.org/10.1111/tan.13084] [PMID: 28695673]
[19]
Prigione I, Penco F, Martini A, Gattorno M, Pistoia V, Morandi F. HLA-G and HLA-E in patients with juvenile idiopathic arthritis. Rheumatology (Oxford) 2011; 50(5): 966-72.
[http://dx.doi.org/10.1093/rheumatology/keq418] [PMID: 21186170]
[20]
van der Helm-van Mil AH, Huizinga TW, Schreuder GMT, Breedveld FC, de Vries RR, Toes RE. An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility. Arthritis Rheum 2005; 52(9): 2637-44.
[http://dx.doi.org/10.1002/art.21272] [PMID: 16142711]
[21]
Ongaro A, Stignani M, Pellati A, et al. Human leukocyte antigen-G molecules are constitutively expressed by synovial fibroblasts and upmodulated in osteoarthritis. Hum Immunol 2010; 71(4): 342-50.
[http://dx.doi.org/10.1016/j.humimm.2010.01.015] [PMID: 20097242]
[22]
Mikdashi J, Nived O. Measuring disease activity in adults with systemic lupus erythematosus: The challenges of administrative burden and responsiveness to patient concerns in clinical research. Arthritis Res Ther 2015; 17(1): 183.
[http://dx.doi.org/10.1186/s13075-015-0702-6] [PMID: 26189728]
[23]
Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: An american college of rheumatology/european league against rheumatism collaborative initiative. Arthritis Rheum 2010; 62(9): 2569-81.
[http://dx.doi.org/10.1002/art.27584] [PMID: 20872595]
[24]
Pistoia Vito, Morandi F, Xinhui W, and Soldano F. Soluble HLA-G: Are they clinically relevant? Semin Cancer Biol 2007; 17: 469-79.
[25]
Rosado S, Perez-Chacon G, Mellor-Pita S, et al. Expression of human leukocyte antigen-G in systemic lupus erythematosus. Hum Immunol 2008; 69(1): 9-15.
[http://dx.doi.org/10.1016/j.humimm.2007.11.001] [PMID: 18295670]
[26]
Rizzo R, Hviid TV, Govoni M, et al. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 2008; 71(6): 520-9.
[http://dx.doi.org/10.1111/j.1399-0039.2008.01037.x] [PMID: 18380776]
[27]
Veit TD, Cordero EA, Mucenic T, et al. Association of the HLA-G 14 bp polymorphism with systemic lupus erythematosus. Lupus 2009; 18(5): 424-30.
[http://dx.doi.org/10.1177/0961203308098187] [PMID: 19318395]
[28]
Verbruggen LA, Rebmann V, Demanet C, De Cock S, Grosse-Wilde H. Soluble HLA-G in rheumatoid arthritis. Hum Immunol 2006; 67(8): 561-7.
[http://dx.doi.org/10.1016/j.humimm.2006.03.023] [PMID: 16916651]
[29]
Rudstein-Svetlicky N, Loewenthal R, Horejsi V, Gazit E. HLA-G levels in serum and plasma. Tissue Antigens 2006; 67(2): 111-6.
[http://dx.doi.org/10.1111/j.1399-0039.2006.00540.x] [PMID: 16441481]
[30]
Rudstein‐Svetlicky N, Loewenthal R, Horejsi V, Gazit E. HLA‐G levels in serum and plasma. Tissue Antigens 2007; 69: 140-2.
[http://dx.doi.org/10.1111/j.1399-0039.2006.763_4.x]
[31]
Veit TD, Chies JAB, Switala M, et al. The paradox of high availability and low recognition of soluble HLA-G by LILRB1 receptor in rheumatoid arthritis patients. PLoS One 2015; 10(4): e0123838.
[http://dx.doi.org/10.1371/journal.pone.0123838] [PMID: 25853899]
[32]
Chen J, Shen B, Jiang Y, et al. Analysis of immunoglobulin-like transcripts (ILTs) in lymphocytes with sHLA-G and IL10 from SLE patients. Clin Exp Med 2013; 13(2): 135-42.
[http://dx.doi.org/10.1007/s10238-012-0185-6] [PMID: 22562117]

Rights & Permissions Print Cite
Article Metrics
5
© 2024 Bentham Science Publishers | Privacy Policy